ABCC1 and cholangiocarcinoma: This compound also reduces the expression of several export pumps, such as MDR1, MRP1 and MRP2, involved in CCA chemoresistance [7,50], enhancing 5-fluorouracil (5-FU), mitomycin C and gemcitabine cytotoxicity in CCA cells [56].